Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen M Feltmate

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Gynecologic Oncology|February 11, 2015
Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?Emeline M Aviki, Katharine M Esselen, Sara M Barcia, et al.
American Journal of Obstetrics and Gynecology|April 8, 2014
What is the optimal treatment for obese patients with advanced ovarian carcinoma?Michael J Worley, Stephanie H Guseh, J Alejandro Rauh-Hain, et al.
JCO Precision Oncology|December 7, 2023
Endometrial Cancer Risk Among Germline <i>BRCA1</i>/<i>2</i> Pathogenic Variant Carriers: Review of Our Current Understanding and Next StepsKimia Sorouri, Filipa Lynce, Colleen M Feltmate, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 25, 2016
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like SyndromeJaclyn C Watkins, Eric J Yang, Michael G Muto, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 27, 2021
Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samplesShuk On Annie Leung, Sarah Feldman, Rajeshwari Kalyanaraman, et al.
Gynecologic Oncology|March 9, 2025
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcomaKevin Tyan, Kevin X Liu, Alicia C Smart, et al.
Cancers|June 2, 2021
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient <i>TP53</i> Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 InteractionsKatherine N Lynch, Joyce F Liu, Nikolas Kesten, et al.
Cancer Discovery|September 15, 2018
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer OrganoidsSarah J Hill, Brennan Decker, Emma A Roberts, et al.
Cancer Research|November 7, 2020
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian CancerChangxin Wan, Matthew P Keany, Han Dong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance StudyTia L Kauffman, Elizabeth K O'Donnell, Catherine R Marinac, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Gynecologic Oncology|February 11, 2015
Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?Emeline M Aviki, Katharine M Esselen, Sara M Barcia, et al.
American Journal of Obstetrics and Gynecology|April 8, 2014
What is the optimal treatment for obese patients with advanced ovarian carcinoma?Michael J Worley, Stephanie H Guseh, J Alejandro Rauh-Hain, et al.
JCO Precision Oncology|December 7, 2023
Endometrial Cancer Risk Among Germline <i>BRCA1</i>/<i>2</i> Pathogenic Variant Carriers: Review of Our Current Understanding and Next StepsKimia Sorouri, Filipa Lynce, Colleen M Feltmate, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 25, 2016
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like SyndromeJaclyn C Watkins, Eric J Yang, Michael G Muto, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 27, 2021
Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samplesShuk On Annie Leung, Sarah Feldman, Rajeshwari Kalyanaraman, et al.
Gynecologic Oncology|March 9, 2025
Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcomaKevin Tyan, Kevin X Liu, Alicia C Smart, et al.
Cancers|June 2, 2021
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient <i>TP53</i> Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 InteractionsKatherine N Lynch, Joyce F Liu, Nikolas Kesten, et al.
Cancer Discovery|September 15, 2018
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer OrganoidsSarah J Hill, Brennan Decker, Emma A Roberts, et al.
Cancer Research|November 7, 2020
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian CancerChangxin Wan, Matthew P Keany, Han Dong, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance StudyTia L Kauffman, Elizabeth K O'Donnell, Catherine R Marinac, et al.
Pageof 5